#BEGINNING_DATE_OF_TREATMENT	#COLLECTION_DATE	#Patient Identifier	#TIME_POINT	#DATE	#TEST_RESULT	#END_DATE_OF_TREATMENT	#EVENT_TYPE	
#BEGINNING_DATE_OF_TREATMENT	#COLLECTION_DATE	#Patient Identifier	#TIME_POINT	#DATE	#TEST_RESULT	#END_DATE_OF_TREATMENT	#EVENT_TYPE	

1	1	1	1	1	1	1	1	
BEGINNING_DATE_OF_TREATMENT	COLLECTION_DATE	PATIENT_ID	TIME_POINT	DATE	TEST_RESULT	END_DATE_OF_TREATMENT	EVENT_TYPE	
217	2018/02/15	CMP-01-02	Baseline	2018/02/15	Yes (0.20%)	NA	CTDNA BLOOD DRAW	
224	2018/02/22	CMP-01-02	Post-Op	2018/02/22	NA	NA	CTDNA BLOOD DRAW	
147	2018/01/25	CMP-01-03	Baseline	2018/01/25	NA	NA	CTDNA BLOOD DRAW	
154	2018/02/01	CMP-01-03	Post-Op	2018/02/01	Yes very weak support (0.20%)	NA	CTDNA BLOOD DRAW	
239	2018/02/07	CMP-01-04	Baseline	2018/02/07	Yes (46.88%)	NA	CTDNA BLOOD DRAW	
269	2018/03/09	CMP-01-04	Post-Op	2018/03/09	Yes (0.20%)	NA	CTDNA BLOOD DRAW	
153	2018/02/14	CMP-01-05	Baseline (1)	2018/02/14	Yes (Very weak, Baselines)  (0.17%)	NA	CTDNA BLOOD DRAW	
159	2018/02/20	CMP-01-05	Baseline (2)	2018/02/20	Yes (Very weak, Baselines)  (0.17%)	NA	CTDNA BLOOD DRAW	
169	2018/03/02	CMP-01-05	Post-Op	2018/03/02	NA	NA	CTDNA BLOOD DRAW	
172	2018/03/09	CMP-01-06	Baseline	2018/03/09	No (Sequence deeper?)	NA	CTDNA BLOOD DRAW	
217	2018/04/23	CMP-01-06	Post-Op	2018/04/23	NA	NA	CTDNA BLOOD DRAW	
204	2018/09/18	CMP-01-07	Baseline	2018/09/18	NA	NA	CTDNA BLOOD DRAW	
300	2018/10/18	CMP-01-08	Baseline	2018/10/18	NA	NA	CTDNA BLOOD DRAW	
448	2018/06/18	CMP-02-01	Baseline	2018/06/18	Yes (0.54%)	NA	CTDNA BLOOD DRAW	
455	2018/06/25	CMP-02-01	Post-Op	2018/06/25	Yes (0.06%)	NA	CTDNA BLOOD DRAW	
294	2018/10/02	CMP-02-02	Baseline	2018/10/02	No	NA	CTDNA BLOOD DRAW	
273	2018/09/04	CMP-02-03	Baseline	2018/09/04	Yes (0.15%)	NA	CTDNA BLOOD DRAW	
276	2018/09/07	CMP-02-03	Post-Op	2018/09/07	Yes (0.45%)	NA	CTDNA BLOOD DRAW	
